Slowing Parkinson's disease progression: recent dopamine agonist trials.
Pan
Tianhong
T
Le
Weidong
W
Jankovic
Joseph
J
D000978:Antiparkinson Agents / Q000494:pharmacology* / Q000627:therapeutic use; D052160:Benzothiazoles; D001692:Biological Transport / Q000187:drug effects; D045744:Cell Line, Tumor / Q000187:drug effects; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology; D018491:Dopamine Agonists / Q000494:pharmacology* / Q000627:therapeutic use; D050483:Dopamine Plasma Membrane Transport Proteins; D006801:Humans; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use; D007980:Levodopa / Q000494:pharmacology / Q000627:therapeutic use; D008562:Membrane Glycoproteins / Q000378:metabolism; D026901:Membrane Transport Proteins / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009447:Neuroblastoma / Q000473:pathology; D010300:Parkinson Disease / Q000188:drug therapy*; D000077487:Pramipexole; D013844:Thiazoles / Q000494:pharmacology* / Q000627:therapeutic use
D000978:Antiparkinson Agents; D052160:Benzothiazoles; D018491:Dopamine Agonists; D050483:Dopamine Plasma Membrane Transport Proteins; D007211:Indoles; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D013844:Thiazoles; C046649:ropinirole; D007980:Levodopa; D000077487:Pramipexole; D004298:Dopamine